Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 320

1.

Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints.

de Velde F, de Winter BC, Koch BC, van Gelder T, Mouton JW; COMBACTE-NET consortium.

J Antimicrob Chemother. 2016 Jun 20. pii: dkw226. [Epub ahead of print]

PMID:
27330071
2.

Pharmacodynamics and differential activity of nitrofurantoin against ESBL-positive pathogens involved in urinary tract infections.

Fransen F, Melchers MJ, Meletiadis J, Mouton JW.

J Antimicrob Chemother. 2016 Jun 7. pii: dkw212. [Epub ahead of print]

PMID:
27278898
3.
4.

Hydrogen cyanide emission in the lung by Staphylococcus aureus.

Neerincx AH, Linders YA, Vermeulen L, Belderbos RA, Mandon J, van Mastrigt E, Pijnenburg MW, van Ingen J, Mouton JW, Kluijtmans LA, Wevers RA, Harren FJ, Cristescu SM, Merkus PJ.

Eur Respir J. 2016 May 26. pii: ERJ-02093-2015. doi: 10.1183/13993003.02093-2015. [Epub ahead of print] No abstract available.

PMID:
27230439
5.

Adverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa.

Mouton JP, Njuguna C, Kramer N, Stewart A, Mehta U, Blockman M, Fortuin-De Smidt M, De Waal R, Parrish AG, Wilson DP, Igumbor EU, Aynalem G, Dheda M, Maartens G, Cohen K.

Medicine (Baltimore). 2016 May;95(19):e3437. doi: 10.1097/MD.0000000000003437.

6.

Bacteroides fragilis in biopsies of patients with major abscesses and diabetic foot infections: direct molecular versus culture-based detection.

Stappers MH, Hagen F, Reimnitz P, Mouton JW, Meis JF, Gyssens IC.

Diagn Microbiol Infect Dis. 2016 Jun;85(2):263-5. doi: 10.1016/j.diagmicrobio.2015.12.017. Epub 2015 Dec 24.

PMID:
27112830
7.

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.

Dickstein Y, Leibovici L, Yahav D, Eliakim-Raz N, Daikos GL, Skiada A, Antoniadou A, Carmeli Y, Nutman A, Levi I, Adler A, Durante-Mangoni E, Andini R, Cavezza G, Mouton JW, Wijma RA, Theuretzbacher U, Friberg LE, Kristoffersson AN, Zusman O, Koppel F, Dishon Benattar Y, Altunin S, Paul M; AIDA consortium.

BMJ Open. 2016 Apr 20;6(4):e009956. doi: 10.1136/bmjopen-2015-009956.

8.

Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease.

Ferro BE, Srivastava S, Deshpande D, Pasipanodya JG, van Soolingen D, Mouton JW, van Ingen J, Gumbo T.

Antimicrob Agents Chemother. 2016 May 23;60(6):3779-85. doi: 10.1128/AAC.02821-15. Print 2016 Jun.

PMID:
27067317
9.

Serum concentrations of amoxicillin in neonates during continuous intravenous infusion.

van Boekholt A, Fleuren H, Mouton J, Kramers C, Sprong T, Gerrits P, Semmekrot B.

Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):1007-12. doi: 10.1007/s10096-016-2630-z. Epub 2016 Apr 2.

PMID:
27039340
10.

Elucidating population-wide mycobacterial replication dynamics at the single-cell level.

Mouton JM, Helaine S, Holden DW, Sampson SL.

Microbiology. 2016 Jun;162(6):966-78. doi: 10.1099/mic.0.000288. Epub 2016 Mar 30.

PMID:
27027532
11.

MYBPH acts as modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients.

Mouton JM, van der Merwe L, Goosen A, Revera M, Brink PA, Moolman-Smook JC, Kinnear C.

Hum Genet. 2016 May;135(5):477-83. doi: 10.1007/s00439-016-1649-7. Epub 2016 Mar 11.

PMID:
26969327
12.

Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis.

Schuts EC, Hulscher ME, Mouton JW, Verduin CM, Stuart JW, Overdiek HW, van der Linden PD, Natsch S, Hertogh CM, Wolfs TF, Schouten JA, Kullberg BJ, Prins JM.

Lancet Infect Dis. 2016 Jul;16(7):847-56. doi: 10.1016/S1473-3099(16)00065-7. Epub 2016 Mar 3.

PMID:
26947617
13.

Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease.

Ferro BE, Srivastava S, Deshpande D, Pasipanodya JG, van Soolingen D, Mouton JW, van Ingen J, Gumbo T.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2895-900. doi: 10.1128/AAC.03112-15. Print 2016 May.

PMID:
26926649
14.

EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.

Arendrup MC, Meletiadis J, Mouton JW, Guinea J, Cuenca-Estrella M, Lagrou K, Howard SJ; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST).

Clin Microbiol Infect. 2016 Jun;22(6):571.e1-4. doi: 10.1016/j.cmi.2016.01.017. Epub 2016 Feb 3.

PMID:
26851656
15.

Identification of Pseudomonas aeruginosa and Aspergillus fumigatus mono- and co-cultures based on volatile biomarker combinations.

Neerincx AH, Geurts BP, Habets MF, Booij JA, van Loon J, Jansen JJ, Buydens LM, van Ingen J, Mouton JW, Harren FJ, Wevers RA, Merkus PJ, Cristescu SM, Kluijtmans LA.

J Breath Res. 2016 Jan 29;10(1):016002. doi: 10.1088/1752-7155/10/1/016002.

PMID:
26824272
16.

Evaluation of nutritional status and support in children with congenital heart disease.

Blasquez A, Clouzeau H, Fayon M, Mouton JB, Thambo JB, Enaud R, Lamireau T.

Eur J Clin Nutr. 2016 Apr;70(4):528-31. doi: 10.1038/ejcn.2015.209. Epub 2015 Dec 23.

PMID:
26695725
17.

Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model.

Ferro BE, Srivastava S, Deshpande D, Sherman CM, Pasipanodya JG, van Soolingen D, Mouton JW, van Ingen J, Gumbo T.

Antimicrob Agents Chemother. 2015 Dec 7;60(3):1242-8. doi: 10.1128/AAC.02282-15.

18.

Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.

Janssen EJ, Välitalo PA, Allegaert K, de Cock RF, Simons SH, Sherwin CM, Mouton JW, van den Anker JN, Knibbe CA.

Antimicrob Agents Chemother. 2015 Dec 7;60(2):1013-21. doi: 10.1128/AAC.01968-15.

19.

Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.

Ferro BE, Meletiadis J, Wattenberg M, de Jong A, van Soolingen D, Mouton JW, van Ingen J.

Antimicrob Agents Chemother. 2015 Dec 7;60(2):1097-105. doi: 10.1128/AAC.02615-15.

20.

Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports.

Njuguna C, Stewart A, Mouton JP, Blockman M, Maartens G, Swart A, Chisholm B, Jones J, Dheda M, Igumbor EU, Cohen K.

Drug Saf. 2016 Feb;39(2):159-69. doi: 10.1007/s40264-015-0359-8.

PMID:
26547719
Items per page

Supplemental Content

Loading ...
Write to the Help Desk